PTGES3 blocking peptide product blog
Tags: PTGES3; Blocking Peptide; PTGES3 blocking peptide;
The PTGES3 ptges3 (Catalog #MBS9221068) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The PTGES3 ptges3 product has the following accession number(s) (GI #8928247) (NCBI Accession #Q15185.1) (Uniprot Accession #Q15185). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2) (PubMed:10922363). Molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes (PubMed:11274138, PubMed:12077419). Facilitates HIF alpha proteins hydroxylation via interaction with EGLN1/PHD2, leading to recruit EGLN1/PHD2 to the HSP90 pathway (PubMed:24711448).
Cellular Location: Cytoplasm. Carcinoma, Cardiomegaly, Chromosome Aberrations, Heart Diseases, Immune System Diseases, Liver Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Vascular Diseases are some of the diseases may be linked to PTGES3 Antibody (Center) Blocking Peptide. Blood, Brain, Embryonic Tissue, Heart, Liver, Lung, Muscle, Ovary, Uterus, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene.